[HTML][HTML] How many myeloid post-progenitor cells have to be transplanted to completely abrogate neutropenia after peripheral blood progenitor cell transplantation …
S Scheding, H Franke, HE Wichmann, W Brugger… - Experimental …, 1999 - Elsevier
Although hematopoietic recovery following high-dose chemotherapy (HD-CT) and
peripheral blood progenitor cell (PBPC) transplantation is rapid, there is still a 5-to 7-day
period of severe neutropenia which, theoretically, might be abrogated by an additional
transplantation of more differentiated myeloid post-progenitor cells (MPPC). However, both
the number of MPPC required to abrogate neutropenia as well as the optimum scheduling of
MPPC infusions are currently unknown. Therefore, these questions were addressed by …
peripheral blood progenitor cell (PBPC) transplantation is rapid, there is still a 5-to 7-day
period of severe neutropenia which, theoretically, might be abrogated by an additional
transplantation of more differentiated myeloid post-progenitor cells (MPPC). However, both
the number of MPPC required to abrogate neutropenia as well as the optimum scheduling of
MPPC infusions are currently unknown. Therefore, these questions were addressed by …
